Shanghai Pharmaceuticals Holding Co., Ltd
HKSE:2607.HK
Sector
Location
Market Cap
USD 8.96 B
Share Price
USD 1.63
Avg Daily Volume
6,587,265
Change (1 day)
0.50%
Change (1 year)
9.10%
Change (YTD)
0.26%
Shanghai Pharmaceuticals Holding Co., Ltd Operating Cash Flow for the year ending December 31, 2024: USD 798.10 M
Shanghai Pharmaceuticals Holding Co., Ltd Operating Cash Flow is USD 798.10 M for the year ending December 31, 2024, a 8.31% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Shanghai Pharmaceuticals Holding Co., Ltd Operating Cash Flow for the year ending December 31, 2023 was USD 736.86 M, a 7.20% change year over year.
-
Shanghai Pharmaceuticals Holding Co., Ltd Operating Cash Flow for the year ending December 31, 2022 was USD 687.36 M, a -13.71% change year over year.
-
Shanghai Pharmaceuticals Holding Co., Ltd Operating Cash Flow for the year ending December 31, 2021 was USD 796.55 M, a -24.04% change year over year.
-
Shanghai Pharmaceuticals Holding Co., Ltd Operating Cash Flow for the year ending December 31, 2020 was USD 1.05 B, a 21.25% change year over year.
StockViz
Competitors
Merck & Co., Inc.
USD 84.06
MRK
-0.65
-0.77%
McKesson Corporation
USD 706.28
MCK
-5.54
-0.78%
Elevance Health Inc.
USD 285.98
ELV
-3.12
-1.08%
Cencora, Inc.
USD 286.20
COR
-4.16
-1.43%
BeOne Medicines Ltd.
USD 294.51
ONC
+3.04
1.04%
JD Health International Inc.
USD 6.24
6618.HK
+0.04
0.65%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.46
2196.HK
+0.04
1.61%
Sinopharm Group Co. Ltd.
USD 2.47
1099.HK
-0.04
-1.49%
Haisco Pharmaceutical Group Co., Ltd.
USD 7.31
002653.SZ
-0.07
-1.01%
Hikma Pharmaceuticals PLC
USD 26.60
HIK.L
-0.33
-1.22%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.31
0874.HK
-0.03
-1.38%
Galenica AG
USD 108.08
GALE.SW
-2.20
-1.99%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.09
600079.SS
+0.02
0.59%
Option Care Health, Inc.
USD 29.77
OPCH
+0.08
0.27%
China Resources Pharmaceutical Group Limited
USD 0.71
3320.HK
-0.00
-0.15%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Merck & Co., Inc.
USD 84.06
MRK
-0.65
-0.77%
McKesson Corporation
USD 706.28
MCK
-5.54
-0.78%
Elevance Health Inc.
USD 285.98
ELV
-3.12
-1.08%
Cencora, Inc.
USD 286.20
COR
-4.16
-1.43%
BeOne Medicines Ltd.
USD 294.51
ONC
+3.04
1.04%
JD Health International Inc.
USD 6.24
6618.HK
+0.04
0.65%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.46
2196.HK
+0.04
1.61%
Sinopharm Group Co. Ltd.
USD 2.47
1099.HK
-0.04
-1.49%
Haisco Pharmaceutical Group Co., Ltd.
USD 7.31
002653.SZ
-0.07
-1.01%
Hikma Pharmaceuticals PLC
USD 26.60
HIK.L
-0.33
-1.22%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.31
0874.HK
-0.03
-1.38%
Galenica AG
USD 108.08
GALE.SW
-2.20
-1.99%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.09
600079.SS
+0.02
0.59%
Option Care Health, Inc.
USD 29.77
OPCH
+0.08
0.27%
China Resources Pharmaceutical Group Limited
USD 0.71
3320.HK
-0.00
-0.15%